ATYR — aTYR PHARMA INC

—
Nasdaq · Health Care · Biotechnology · CIK 1339970 ·
Last close
$4.99
Market Cap
$12.47M
52W High
$44.40
52W Low
$4.08
ADV30
91,280
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -18,792,000 -18,261,000 59,806,000 13,140,000 26,014,000
Jun 2026 0 — -10,881,000 -10,309,000 69,825,000 16,160,000 21,231,000
Mar 2026 0 — -11,436,000 -10,791,000 79,654,000 10,008,000 21,913,000
Dec 2025 0 — -14,796,000 -13,963,000 93,003,000 10,743,000 25,715,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-54,540,000
Investing CF
$22,882,000
Financing CF
$29,215,000
CapEx
$-279,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-24.80
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-627,264,000
Inventory
—
Receivables
$426,000
ST Investments
$41,258,000
EBIT TTM
$-63,858,000
Pretax Income TTM
$-60,812,000
Interest Exp TTM
—
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$0
EBITDA
$-55,235,000
Free Cash Flow
$-31,708,250
Enterprise Value
$-23,734,082
Total Cash
$50,253,000
Total Debt
$10,919,000
Shares Out
2,500,000
Trailing EPS
$-21.64
Book Value
$13.76
ROE
-93.7%
ROA
-42.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 190,000 -77,627,000 -74,118,000 93,003,000 25,715,000 67,480,000 -61,986,000
Dec 2024 235,000 -67,914,000 -64,023,000 96,830,000 26,998,000 70,019,000 -69,119,000
Dec 2023 353,000 -54,919,000 -50,389,000 120,653,000 30,183,000 90,658,000 -33,221,000
Dec 2022 10,386,000 -46,404,000 -45,338,000 95,786,000 24,502,000 71,464,000 -41,886,000

TTM Snapshot

Revenues TTM
$190,000
NetIncome TTM
$-60,807,000
OpCashFlow TTM
—
Assets (Latest)
$69,825,000
Forward EPS
$-18.74

Max Pain — expiry 2027-01-15

max pain strike: $2.50 · spot: $4.08 · call oi: 9,333 · put oi: 197

Peers — same industry

TickerNameMarket CapLastDaily %
DYAI DYADIC INTERNATIONAL INC $12.66M $0.32 —
BCDA BioCardia, Inc. $11.93M $0.79 —
PASG Passage BIO, Inc. $13.58M $4.22 —
PLUR Pluri Inc. $14.09M $0.98 —
GRML Greenland Mines Ltd $10.87M $3.42 —

News headlines (Yahoo Finance, 1h cache)

aTyr Pharma (ATYR) Stock Fair Value Moves Lower As Phase III Funding Risks Loom
2026-11-14 02:09 · Yahoo
aTyr Pharma to Participate in Upcoming Investor Conferences
2026-11-11 13:00 · Yahoo
Atyr Pharma: Q3 Earnings Snapshot
2026-11-05 21:26 · Yahoo
aTyr Pharma Announces Third Quarter 2026 Results and Provides Corporate Update
2026-11-05 21:01 · Yahoo
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
2026-10-29 12:00 · Yahoo
aTyr Pharma Announces One-for-40 Reverse Stock Split
2026-10-27 13:00 · Yahoo
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
2026-10-19 11:00 · Yahoo
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
2026-10-13 12:00 · Yahoo
aTyr Pharma FDA Alignment Sets Protocol for Phase 3 Efzofitimod Study in Pulmonary Sarcoidosis
2026-09-24 14:59 · Yahoo
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
2026-09-24 10:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.